Chlorothiazide/Methyldopa

氯噻嗪/甲基多巴

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChlorothiazide/Methyldopa
Drug Alias NameMethyldopa-Chlorothiazide甲基多巴和氯噻嗪氯噻嗪甲基多巴Methyldopa and ChlorothiazideChlorothiazide and Methyldopa +[9] 
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors alpha-2 agonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAdrenergic receptors alpha-2
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1962/12/20
Country/TerritoryUnited States
CombinationsYes ChlorothiazideMethyldopa
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC02LB01
Related LinksN/A